Non-peptide fibrinogen receptor antagonists. 3. design and discovery of a centrally constrained inhibitor
- 11 August 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (15) , 1835-1840
- https://doi.org/10.1016/s0960-894x(01)80380-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptideJournal of the American Chemical Society, 1993
- Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptorJournal of Medicinal Chemistry, 1993
- Chapter 9. Glycoprotein IIb IIIa AntagonistsPublished by Elsevier ,1993
- The first design and synthesis of a steroidal peptidomimetic. The potential value of peptidomimetics in elucidating the bioactive conformation of peptide ligandsJournal of the American Chemical Society, 1992
- Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitorsJournal of Medicinal Chemistry, 1992
- Low molecular weight, non-peptide fibrinogen receptor antagonistsJournal of Medicinal Chemistry, 1992
- Design and synthesis of a C7 mimetic for the predicted .gamma.-turn conformation found in several constrained RGD antagonistsJournal of Medicinal Chemistry, 1992
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular modelJournal of the American Chemical Society, 1985
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985